Poster Session D - Tuesday Morning
Category: Biliary/Pancreas
Muhammad Salman Faisal, MD
Henry Ford Hospital
Detroit, MI
Table 1: Patient and procedural characteristics. | |
Age, Mean ± SD | 66.4 (12.0) |
Gender, Male N (%) | 5 (35.7) |
Indication, N (%) |
|
Stone Removal/Decompression | 13 (92.9) |
Stricture Diagnosis | 1 (7.1) |
Altered anatomy. N (%) |
|
Roux-en-Y Gastric Bypass | 10 (71.4) |
Billroth II | 1 (7.1) |
Duodenal Switch | 2 (14.2) |
Hepaticojejunostomy | 1 (7.1) |
Prior ERCP Attempt, N (%) | 3 (21.4) |
Prior EDGE Attempt, N (%) | 1 (7.1) |
Preprocedural Labs, Mean ± SD |
|
ALT (IU/L) | 89.9 ± 116.1 |
ALP (IU/L) | 295.4 ± 210.6 |
Total Bilirubin (mg/dL) | 1.8 ± 1.9 |
Findings N (%) |
|
Multiple Stones | 10 (71.4) |
Single Stone | 2 (14.2) |
Stricture | 3 (21.3) |
No Stone | 1 (7.1) |
Number of Sessions, Median (IQR) | 1 (1-2) |
Therapeutic Device, N (%) |
|
EHL | 8 (57.1) |
Balloon | 5 (35.7) |
Basket | 2 (14.3) |
Spybites, N (%) | 3 (21.4) |
Success, N (%) | 13 (92.9) |
Complication, N (%) | 0 (0) |
Follow up Months, Median (IQR) | 28.5 (17-36) |
ERCP: Endoscopic Retrograde Cholangio Pancreatography, EDGE: Endoscopic ultrasound Directed transGastric ERCP, ALT: Alanine aminotransferase, ALP: Alkaline Phosphatase |